Volume 26, Issue 1p2 pp. 471-473

Use of the AutoCapture Pacing System with Implantable Defibrillator Leads

JOHN P. MARENCO

JOHN P. MARENCO

New England Medical Center, Boston, MA

Search for more papers by this author
RUTH ANN GREENFIELD

RUTH ANN GREENFIELD

Duke University Medical Center, Durham, NC

Search for more papers by this author
ALI MASSUMI

ALI MASSUMI

St. Luke's Episcopal Hospital, Houston, TX

Search for more papers by this author
ZAFFER A. SYED

ZAFFER A. SYED

St. Jude Medical, Sylmar, California

Search for more papers by this author
TIMOTHY MCINTYRE

TIMOTHY MCINTYRE

St. Jude Medical, Sylmar, California

Search for more papers by this author
MICHAEL HARDAGE

MICHAEL HARDAGE

St. Jude Medical, Sylmar, California

Search for more papers by this author
MARK S. LINK

MARK S. LINK

New England Medical Center, Boston, MA

Search for more papers by this author
MUNTHER K. HOMOUD

MUNTHER K. HOMOUD

New England Medical Center, Boston, MA

Search for more papers by this author
MARK ESTES III

MARK ESTES III

New England Medical Center, Boston, MA

Search for more papers by this author
PAUL J. WANG

PAUL J. WANG

New England Medical Center, Boston, MA

Search for more papers by this author
First published: 28 March 2003
Citations: 7
Address for reprints: Paul J. Wang, M.D., Division of Cardiology, Tufts New England Medical Center, 750 Washington Street, Box 197, Boston, MA 02111. Fax: (617)-636-4586; e-mail: [email protected]

This study was supported by St. Jude Medical, CRMD, Sylmar, California.

Abstract

MARENCO, J.P., et al.: Use of the AutoCapture Pacing System with Implantable Defibrillator Leads. Introduction: Previous studies using various bipolar pacemaker leads have shown that the AutoCapture (AC) Pacing System is able to verify ventricular capture and regulate pacing output, increasing patient safety with respect to unexpected threshold changes and potentially prolonging device longevity. An increasing number of patients with implantable cardioverter defibrillators (ICDs) require ventricular pacing that contributes to a shortening of longevity of these systems. This prospective study tested the compatibility of the AC system with bipolar ICD leads. Methods: The AC algorithm was evaluated prior to ICD testing in 30 ICD recipients. A single coil, active fixation, true bipolar ventricular lead was implanted in 21 patients, and a dual coil, passive fixation, integrated bipolar ventricular lead was implanted in 9 patients. A ventricular evoked response sensitivity test and an AC threshold test were performed using a pacemaker with the ventricular AC algorithm. Results: AC was recommended in 22/30 (73.3%) of implants, including 20/21 (95.2%) with the single coil and 2/9 (22.2%) with the dual coil lead. Mean polarization was lower ( 1.23 ± 0.95 mV vs 3.70 ± 2.33 mV, P = 0.013 ) while the mean evoked response was higher ( 18.04 ± 8.29 mV vs 10.13 ± 4.22 mV, P = 0.002 ) with the single coil leads. Conclusion: Automatic threshold tracking using the AC is compatible with ICD leads. Leads with lower polarization and greater evoked response are more likely to result in recommendation of AC use. Use of this system offers the potential for increasing ICD generator longevity and improving patient safety in response to late unexpected threshold increases. (PACE 2003; 26[Pt. II]:471–473)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.